% latex table generated in R 3.4.1 by xtable 1.8-2 package
% Wed Jan 30 23:14:42 2019
  \hline
ARCHER 1050 & Dacomitinib & Dacomitinib, PO (45mg; D1; Cycle length: 1 day(s); UDP) & -- & -- \\ 
  ARCHER 1050 & Gefitinib & Gefitinib, PO (250mg; D1; Cycle length: 1 day(s); UDP) & -- & -- \\ 
  ENSURE & Erlotinib & Erlotinib, PO (150mg; D1; Cycle length: 1 day(s); UDP) & -- & -- \\ 
  ENSURE & Gemcitabine + Carboplatin & Gemcitabine, IV (1250mg/m2; D1, D8; Cycle length: 3 week(s); Max no. cycles: 4 cycle(s)) & Cisplatin, IV (75mg/m2; D1; Cycle length: 3 week(s); Max no. cycles: 4 cycle(s)) & -- \\ 
  EURTAC & Erlotinib & Erlotinib, PO (150mg; D1; Cycle length: 1 day(s); UDP) & -- & -- \\ 
  EURTAC & Cisplatin + Docetaxel & Cisplatin, IV (75mg/m2; D1; Cycle length: 3 week(s); Max no. cycles: 4 cycle(s)) & Docetaxel, IV (75mg/m2; D1; Cycle length: 3 week(s); Max no. cycles: 4 cycle(s)) & -- \\ 
  EURTAC & Cisplatin + Gemcitabine & Cisplatin, IV (75mg/m2; D1; Cycle length: 3 week(s); Max no. cycles: 4 cycle(s)) & Gemcitabine, IV (1250mg/m2; D1, D8; Cycle length: 3 week(s); Max no. cycles: 4 cycle(s)) & -- \\ 
  EURTAC & Carboplatin + Docetaxel & Carboplatin, IV (AUC 6--; D1; Cycle length: 3 week(s); Max no. cycles: 4 cycle(s)) & Docetaxel, IV (75mg/m2; D1; Cycle length: 3 week(s); Max no. cycles: 4 cycle(s)) & -- \\ 
  EURTAC & Carboplatin + Gemcitabine & Carboplatin, IV (AUC 6--; D1; Cycle length: 3 week(s); Max no. cycles: 4 cycle(s)) & Gemcitabine, IV (1000mg/m2; D1, D8; Cycle length: 3 week(s); Max no. cycles: 4 cycle(s)) & -- \\ 
  First-SIGNAL & Gefitinib & Gefitinib, PO (250mg; D1; Cycle length: 1 day(s); UDP) & -- & -- \\ 
  First-SIGNAL & Gemcitabine + Cisplatin & Gemcitabine, IV (1250mg/m2; D1, D8; Cycle length: 3 week(s); Max no. cycles: 9 cycle(s)) & Cisplatin, IV (75mg/m2; D1; Cycle length: 3 week(s); Max no. cycles: 9 cycle(s)) & -- \\ 
  FLAURA & Osimertinib & Osimertinib, PO (80mg; D1; Cycle length: 1 day(s); UDP) & -- & -- \\ 
  FLAURA & Gefitinib & Gefitinib, PO (250mg; D1; Cycle length: 1 day(s); UDP) & -- & -- \\ 
  FLAURA & Erlotinib & Erlotinib, PO (150mg; D1; Cycle length: 1 day(s); UDP) & -- & -- \\ 
  Han2017 & Carboplatin + Pemetrexed & Carboplatin, IV (AUC 5--; D1; Cycle length: 4 week(s); Max no. cycles: 6 cycle(s)) & Pemetrexed, -- (500mg/m2; D1; Cycle length: 4 week(s); UDP) & -- \\ 
  Han2017 & Gefitinib & Gefitinib, PO (250mg; D1; Cycle length: 1 day(s); UDP) & -- & -- \\ 
  IPASS & Gefitinib & Gefitinib, PO (250mg; D1; Cycle length: 1 day(s); UDP) & -- & -- \\ 
  IPASS & Carboplatin + Paclitaxel & Carboplatin, IV (AUC 5 or 6 over 15-60 min; D1; Cycle length: 3 week(s); Max no. cycles: 6 cycle(s)) & Paclitaxel, IV (200mg/m2 over 3 hours; D1; Cycle length: 3 week(s); Max no. cycles: 6 cycle(s)) & -- \\ 
  LUX-LUNG 3 & Afatinib & Afatinib, PO (40mg; D1; Cycle length: 1 day(s); UDP) & -- & -- \\ 
  LUX-LUNG 3 & Pemetrexed + Cisplatin & Pemetrexed, IV (500mg/m2; D1; Cycle length: 3 week(s); Max no. cycles: 6 cycle(s)) & Cisplatin, IV (75mg/m2; D1; Cycle length: 3 week(s); Max no. cycles: 6 cycle(s)) & -- \\ 
  LUX-LUNG 6 & Afatinib & Afatinib, PO (40mg; D1; Cycle length: 1 day(s); UDP) & -- & -- \\ 
  LUX-LUNG 6 & Gemcitabine + Cisplatin & Gemcitabine, IV (1000mg/m2; D1, D8; Cycle length: 3 week(s); UDP) & Cisplatin, IV (75mg/m2; D1; Cycle length: 3 week(s); UDP) & -- \\ 
  LUX-LUNG 7 & Afatinib & Afatinib, PO (40mg; D1; Cycle length: 1 day(s); UDP) & -- & -- \\ 
  LUX-LUNG 7 & Gefitinib & Gefitinib, PO (250mg; D1; Cycle length: 1 day(s); UDP) & -- & -- \\ 
  NEJ002 & Gefitinib & Gefitinib, PO (250mg; D1; Cycle length: 1 day(s); UDP) & -- & -- \\ 
  NEJ002 & Paclitaxel + Carboplatin & Paclitaxel, IV (200mg/m2 over 3 hour; D1; Cycle length: 3 week(s); UDP) & Carboplatin, IV (AUC 6 over1 hour; D1; Cycle length: 3 week(s); UDP) & -- \\ 
  OPTIMAL & Erlotinib & Erlotinib, PO (150mg; D1; Cycle length: 1 day(s); UDP) & -- & -- \\ 
  OPTIMAL & Gemcitabine + Carboplatin & Gemcitabine, IV (1000mg/m2; D1, D8; Cycle length: 3 week(s); Max no. cycles: 4 cycle(s)) & Carboplatin, IV (AUC 5--; D1; Cycle length: 3 week(s); Max no. cycles: 4 week(s)) & -- \\ 
  WJTOG3405 & Gefitinib & Gefitinib, PO (250mg; D1; Cycle length: 1 day(s); UDP) & -- & -- \\ 
  WJTOG3405 & Docetaxel + Cisplatin & Docetaxel, IV (60mg/m2 over 1 h period; D1; Cycle length: 3 week(s); Max no. cycles: 3 to 6 cycle(s)) & Cisplatin, IV (80mg/m2 over 90 min; D1; Cycle length: 3 week(s); Max no. cycles: 3 to 6 cycle(s)) & -- \\ 
  Yang2014 & Cisplatin + Pemetrexed followed by Gefitinib maintenance & Cisplatin, IV (75mg/m2; D1; Cycle length: 3 week(s); Max no. cycles: 6 cycle(s)) & Pemetrexed, IV (500mg/m2 over 10 min; D1; Cycle length: 3 week(s); Max no. cycles: 6 cycle(s)) & Gefitinib, PO (250mg; D1; Cycle length: 1 day(s); UDP) \\ 
  Yang2014 & Gefitinib & Gefitinib, PO (250mg; D1; Cycle length: 1 day(s); UDP) & -- & -- \\ 
   \hline
